Sugi Predict

Sugi Predict / Compounds / SCHEMBL10115948

SCHEMBL10115948

SCHEMBL10115948

CC(C)S(=O)(=O)NC1CCN(C(=O)Nc2ccc(C(C)(C)O)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ CNR2 P34972 6/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ EPHX2 P34913 4/20 0.44
▸ CNR1 P21554 2/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ NAMPT P43490 1/20 0.43
▸ TRPV1 Q8NER1 1/20 0.43
▸ TSHR P16473 1/20 0.42
▸ CCR8 P51685 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10115869 0.92 CNR2 (0.54) LMNANPSR1CNR2KMT2AEPHX2
SCHEMBL10115939 0.89 LMNA (0.46) LMNANPSR1CNR2KMT2AEPHX2
SCHEMBL10114622 0.89 EPHX2 (0.57) CNR2EPHX2CNR1TRPV1
SCHEMBL10115614 0.86 LMNA (0.51) LMNANPSR1CNR2KMT2AEPHX2
SCHEMBL10115847 0.86 LMNA (0.59) LMNANPSR1KMT2AEPHX2TSHR
SCHEMBL12882838 0.86 TSHR (0.48) LMNANPSR1KMT2AEPHX2TSHR
SCHEMBL13222448 0.86 GAA (0.50) LMNANPSR1KMT2AEPHX2CA12
SCHEMBL10116128 0.86 KMT2A (0.50) LMNANPSR1CNR2KMT2AEPHX2
SCHEMBL10115929 0.85 LMNA (0.48) LMNANPSR1CNR2KMT2AEPHX2
SCHEMBL10115855 0.85 NPC1 (0.57) LMNANPSR1CNR2KMT2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R LMNA 1925/4885NPSR1 7/4885CNR2 29/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R LMNA 2068/4885NPSR1 8/4885CNR2 30/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R LMNA 1857/4885NPSR1 7/4885CNR2 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.